4.8 Article

MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53

期刊

MOLECULAR CELL
卷 61, 期 1, 页码 68-83

出版社

CELL PRESS
DOI: 10.1016/j.molcel.2015.12.008

关键词

-

资金

  1. Else Kroner-Fresenius-Stiftung
  2. German Cancer Aid/Dr. Mildred Scheel Stiftung
  3. Wilhelm Sander Stiftung
  4. Deutsche Jose Carreras Stiftung
  5. German Research Foundation (DFG) [JO 815/3-1]
  6. Studienstiftung des Deutschen Volkes
  7. German Ministry for Education and Research (BMBF) [01KU1401A]
  8. Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences (GGNB)
  9. Novo Nordisk Fonden [NNF15OC0016284] Funding Source: researchfish

向作者/读者索取更多资源

The MDM2 oncoprotein ubiquitinates and antagonizes p53 but may also carry out p53-independent functions. Here we report that MDM2 is required for the efficient generation of induced pluripotent stem cells (iPSCs) from murine embryonic fibroblasts, in the absence of p53. Similarly, MDM2 depletion in the context of p53 deficiency also promoted the differentiation of human mesenchymal stem cells and diminished clonogenic survival of cancer cells. Most of the MDM2-controlled genes also responded to the inactivation of the Polycomb Repressor Complex 2 (PRC2) and its catalytic component EZH2. MDM2 physically associated with EZH2 on chromatin, enhancing the trimethylation of histone 3 at lysine 27 and the ubiquitination of histone 2A at lysine 119 (H2AK119) at its target genes. Removing MDM2 simultaneously with the H2AK119 E3 ligase Ring1B/RNF2 further induced these genes and synthetically arrested cell proliferation. In conclusion, MDM2 supports the Polycomb-mediated repression of lineage-specific genes, independent of p53.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据